Interpore Cross International

Interpore Cross International was a prominent medical device company specializing in the development and commercialization of spinal implants and orthobiologic products. The company was widely recognized for its ProOsteon line, which utilized proprietary technology to create bone graft substitutes from marine coral. In addition to its biologics portfolio, the firm offered a comprehensive suite of spinal fixation systems, including the Synergy and Fasten brands, designed for complex spinal reconstructions. Formed through the strategic merger of Interpore International and Cross Medical Products, the entity became a significant player in the global orthopedic market. In 2004, the company was acquired by Biomet for approximately $280 million, eventually becoming part of Zimmer Biomet's spinal division.